Literature DB >> 21873608

Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA.

Janey L Wiggs1, Jae Hee Kang, Brian L Yaspan, Daniel B Mirel, Cathy Laurie, Andrew Crenshaw, Wendy Brodeur, Stephanie Gogarten, Lana M Olson, Wael Abdrabou, Elizabeth DelBono, Stephanie Loomis, Jonathan L Haines, Louis R Pasquale.   

Abstract

Primary open-angle glaucoma (POAG) is a genetically complex common disease characterized by progressive optic nerve degeneration that results in irreversible blindness. Recently, a genome-wide association study (GWAS) for POAG in an Icelandic population identified significant associations with single nucleotide polymorphisms (SNPs) between the CAV1 and CAV2 genes on chromosome 7q31. In this study, we confirm that the identified SNPs are associated with POAG in our Caucasian US population and that specific haplotypes located in the CAV1/CAV2 intergenic region are associated with the disease. We also present data suggesting that associations with several CAV1/CAV2 SNPs are significant mostly in women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873608      PMCID: PMC3209825          DOI: 10.1093/hmg/ddr382

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  36 in total

1.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  A model of giant vacuole dynamics in human Schlemm's canal endothelial cells.

Authors:  Ryan M Pedrigi; David Simon; Ashley Reed; W Daniel Stamer; Darryl R Overby
Journal:  Exp Eye Res       Date:  2010-11-12       Impact factor: 3.467

3.  Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes.

Authors:  Núria Comes; Teresa Borrás
Journal:  Physiol Genomics       Date:  2009-04-28       Impact factor: 3.107

4.  [Effect of hormone replacement therapy on postmenopausal ocular function].

Authors:  C Sorrentino; P Affinito; F Mattace Raso; M Loffredo; P Merlino; A Loffredo; S Palomba; C Nappi
Journal:  Minerva Ginecol       Date:  1998 Jan-Feb

Review 5.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

6.  Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17beta-estradiol.

Authors:  Neetu Sud; Dean A Wiseman; Stephen M Black
Journal:  Mol Endocrinol       Date:  2010-07-07

7.  ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.

Authors:  Naoki Terasaka; Marit Westerterp; Joris Koetsveld; Carlos Fernández-Hernando; Laurent Yvan-Charvet; Nan Wang; William C Sessa; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

8.  The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow.

Authors:  Ozgül Altintaş; Yusuf Caglar; Nurşen Yüksel; Ali Demirci; Levent Karabaş
Journal:  Ophthalmologica       Date:  2004 Mar-Apr       Impact factor: 3.250

9.  Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study.

Authors:  Louis R Pasquale; Bernard A Rosner; Susan E Hankinson; Jae Hee Kang
Journal:  J Glaucoma       Date:  2007 Oct-Nov       Impact factor: 2.503

10.  Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma.

Authors:  Xiaohong Zhou; Feng Li; Jian Ge; Steven R Sarkisian; Hiroshi Tomita; Alexander Zaharia; James Chodosh; Wei Cao
Journal:  Dev Neurobiol       Date:  2007-04       Impact factor: 3.964

View more
  91 in total

Review 1.  Genes, pathways, and animal models in primary open-angle glaucoma.

Authors:  A I Iglesias; H Springelkamp; W D Ramdas; C C W Klaver; R Willemsen; C M van Duijn
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

Review 2.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

3.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

4.  Lack of gene-diuretic interactions on the risk of incident gout: the Nurses' Health Study and Health Professionals Follow-up Study.

Authors:  Ying Bao; Gary Curhan; Tony Merriman; Robert Plenge; Peter Kraft; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2015-02-09       Impact factor: 19.103

5.  Investigation of known genetic risk factors for primary open angle glaucoma in two populations of African ancestry.

Authors:  Yutao Liu; Michael A Hauser; Stephen K Akafo; Xuejun Qin; Shiroh Miura; Jason R Gibson; Joshua Wheeler; Douglas E Gaasterland; Pratap Challa; Leon W Herndon; Robert Ritch; Sayoko E Moroi; Louis R Pasquale; Christopher A Girkin; Donald L Budenz; Janey L Wiggs; Julia E Richards; Allison E Ashley-Koch; R Rand Allingham
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

6.  Habitual consumption of long-chain n-3 PUFAs and fish attenuates genetically associated long-term weight gain.

Authors:  Tao Huang; Tiange Wang; Yoriko Heianza; Yan Zheng; Dianjianyi Sun; Jae H Kang; Louis R Pasquale; Eric B Rimm; JoAnn E Manson; Frank B Hu; Lu Qi
Journal:  Am J Clin Nutr       Date:  2019-03-01       Impact factor: 7.045

7.  Clinical and genetic characterization of a large primary open angle glaucoma pedigree.

Authors:  Mohideen Abdul Kader; Prasanthi Namburi; Sarika Ramugade; R Ramakrishnan; Subbiah R Krishnadas; Ben R Roos; Sundaresan Periasamy; Alan L Robin; John H Fingert
Journal:  Ophthalmic Genet       Date:  2016-06-29       Impact factor: 1.803

8.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

Review 9.  Intraocular pressure homeostasis: maintaining balance in a high-pressure environment.

Authors:  Ted S Acott; Mary J Kelley; Kate E Keller; Janice A Vranka; Diala W Abu-Hassan; Xinbo Li; Mini Aga; John M Bradley
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-08       Impact factor: 2.671

10.  Genetic Susceptibility, Change in Physical Activity, and Long-term Weight Gain.

Authors:  Tiange Wang; Tao Huang; Yoriko Heianza; Dianjianyi Sun; Yan Zheng; Wenjie Ma; Majken K Jensen; Jae H Kang; Janey L Wiggs; Louis R Pasquale; Eric B Rimm; JoAnn E Manson; Frank B Hu; Walter C Willett; Lu Qi
Journal:  Diabetes       Date:  2017-07-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.